SCHEMBL24503566

SCHEMBL24503566

COc1ccc(CC(C)C)cc1S(=O)(=O)Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV4 Q9HBA0 1/20 0.45
▸ TRIM24 O15164 1/20 0.45
▸ ALOX15 P16050 2/20 0.44
▸ ALOX12 P18054 2/20 0.44
▸ LDHA P00338 1/20 0.43
▸ ADRA1D P25100 5/20 0.42
▸ ADRA1A P35348 5/20 0.42
▸ ADRA1B P35368 5/20 0.42
▸ ADRB2 P07550 1/20 0.42
▸ ADRB1 P08588 1/20 0.42
▸ HTR1A P08908 1/20 0.42
▸ ADRA2A P08913 1/20 0.42
▸ DRD2 P14416 1/20 0.42
▸ ADRA2B P18089 1/20 0.42
▸ ADRA2C P18825 1/20 0.42
▸ HTR2A P28223 1/20 0.42
▸ HTR7 P34969 1/20 0.42
▸ OPRM1 P35372 1/20 0.42
▸ DRD3 P35462 1/20 0.42
▸ HTR2B P41595 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14368066 0.84 ADRA1D (0.56) TRIM24ALOX15ALOX12ADRA1DADRA1A
SCHEMBL23823918 0.84 TRIM24 (0.50) TRIM24ALOX15ALOX12LDHAADRA1D
SCHEMBL13623710 0.84 TRPV4 (0.40) TRPV4TRIM24ALOX15ALOX12LDHA
SCHEMBL741235 0.82 ALPL (0.51) TRPV4SMN1; SMN2
SCHEMBL8180786 0.79 TRPV4 (0.46) TRPV4ALDH1A1SMN1; SMN2GAA
SCHEMBL5903990 0.79 ACACB (0.45) TRIM24LDHAADRA1DADRA1AADRA1B
SCHEMBL5807725 0.79 ACACB (0.45) TRIM24LDHAADRA1DADRA1AADRA1B
SCHEMBL9724436 0.77 CA5A (0.61) TRPV4ALDH1A1GAA
SCHEMBL30997420 0.77 CA5A (0.47) TRPV4ALDH1A1SMN1; SMN2GAA
SCHEMBL4660848 0.77 CA5A (0.47) TRPV4ALDH1A1SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11357873-B2 Chiral cyclen compounds and their uses THE HONG KONG POLYTECHNIC UNIVERSITY (CN) 2022-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11357873-B2 Chiral cyclen compounds and their uses DCTN3, DCTN1, CDK3 TRPV4 3080/4885TRIM24 4769/4885ALOX15 4628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback